Retinal Detachment After Lens Surgery in the Nearsighted

NCT ID: NCT04072939

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

101 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-05-31

Study Completion Date

2006-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to study the incidence of retinal detachment in the nearsighted myopic after phakoemulsification lens surgery and use of posterior chamber foldable soft implants with a follow-up of 5 years and preliminary results at 3 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Major advances have been made in the field of lens surgery over the last 20 years which has significantly reduced the per and postoperative complications of this surgery. Retinal detachment remains the most feared complication of this surgery in the nearsighted.

There is currently an increasing popularity in the international ophthalmic community for the correction of ametropia, particularly nearsightedness, by ablation of the non-cataracted lens, referred to as refractive lensectomy. However, no recent study reports the complications of this procedure with the use of modern surgical techniques.

This study aims to study the incidence of retinal detachment in the nearsighted myopic after phakoemulsification lens surgery and use of posterior chamber foldable soft implants with a follow-up of 5 years and preliminary results at 3 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment Lens Diseases Short-Sighted

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single arm

dilated fundus exam

Patients having had a lens surgery

Intervention Type OTHER

Dilated fundus exam

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients having had a lens surgery

Dilated fundus exam

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent form.
* Male or female aged 20 to 60 included.
* Myopia: axile, united or bilateral.
* Degree of myopia: Axial length of the eye to be operated ≥ 26 mm, measured by ultrasound A or B.
* Preoperative visual acuity of the eye to be operated ≥ 0.2.
* Crystalline eye to operate natural: clear or opacified (allowed: cataract complicating a myopic implant and cataract after corneal refractive surgery.

Exclusion Criteria

* History of retinal detachment on the eye to be operated or the eye to help.
* History of glaucoma of the eye to operate.
* intraocular pressure of the eye to operate ≥ 21 mmHg.
* History of diabetic retinopathy.
* History of anterior or posterior intraocular inflammation in the year preceding surgery.
* History of vitreoretinal syndrome (Stickler's disease ...).
* Unstable systemic pathology in the month preceding the preoperative check-up (Visit 1) (example: uncontrolled hypertension, diabetes with abnormal glycemia, thyroid disorders, uncontrolled autoimmune diseases, etc.) or deemed by the investigator to be incompatible with the study (example: hepatic or renal insufficiency, all severe chronic organic diseases: metabolic, endocrine, neoplastic, hematological, etc., severe psychiatric diseases).
* Pregnancy, breastfeeding.
* History of filter surgery of the eye to be operated.
* History of vitreoretinal surgery of the eye to be operated (authorized after Day 0).
* Patient unable to understand the instructions of the study or not likely to comply with the course of the study and treatment.
* Participation in another clinical trial in the month preceding the start of this study, at the same time as this study.
* Patient not covered by the French social security system.
* Major patient under guardianship.
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph COLIN, Pr

Role: PRINCIPAL_INVESTIGATOR

Bordeaux University hsopital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2004/03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.